Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $17.0400 (-1.22%) ($17.0400 - $17.0400) on Wed. Dec. 29, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.68% (three month average) | RSI | 44 | Latest Price | $17.0400(-1.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.7% a day on average for past five trading days. | Weekly Trend | ATRA advances 2.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) IBB(47%) ARKG(46%) ARKK(46%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.84% in a week (0% probabilities). VIXM(-42%) VXX(-31%) UNG(-17%) USO(-13%) TLT(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.84% (StdDev 3.68%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $17(0.24%) | 10 Day Moving Average | $16.31(4.48%) | 20 Day Moving Average | $16.54(3.02%) | To recent high | -14.3% | To recent low | 16% | Market Cap | $1.266b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |